乳腺X线摄影、超声及磁共振诊断乳腺癌的性能评价

doi:10.12117/jccmi.2020.01.005

Abstract
Figure/Table
References (22)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore and compare the clinical value of mammography, ultrasound and MRI in the diagnostic accuracy of breast cancer. Methods: One hundred and twenty-nine suspected breast cancer patients(26 to 75 years old) from July 2011 to June 2017 in our hospital were selected. All patients underwent mammography, ultrasound and MRI within one month. The positive predict value(PPV), negative predict value(NPV), accuracy, sensitivity, specificity of double imaging modalities were analyzed and compared by constructing a summary of receiver-operating characteristic(ROC) curves, area under the ROC curve(AUC). Results: The PPV and NPV of mammography and ultrasound in breast cancer was lower than that of MRI(89.5%, 98.1%). The accuracy(93.0%), sensitivity(98.6%) and AUC(0.938) of MRI in the diagnosis of breast cancer were significantly higher than the accuracy(72.9%), sensitivity(85.5%), AUC(0.806) of mammography, and accuracy(73.6%), sensitivity(71.0%) and AUC(0.814) of ultrasound(P<0.000 1). Conclusion: The accuracy, sensitivity, and AUC of MRI in the diagnosis of breast lesions are higher than mammography and ultrasound. And the performance of MRI is better in distinguishing malignant from benign breast carcinoma.

Key words： Breast neoplasms Radiography Ultrasonography Magnetic resonance imaging

Received: 28 February 2019

PACS:	Ｒ737.9
	Ｒ814.41
	Ｒ445.1
	Ｒ445.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SI Shuang
	ZHANG Wei
	WANG Hui-ying
	LIANG Chang

Cite this article:

SI Shuang,ZHANG Wei,WANG Hui-ying, et al. Performance evaluation of breast cancer diagnosed with mammography, ultrasound and MRI[J]. JOURNAL OF CHINA MEDICAL IMAGING, 2020, 31(1): 20-23.

URL:

http://www.jccmi.com.cn/EN/10.12117/jccmi.2020.01.005 OR http://www.jccmi.com.cn/EN/Y2020/V31/I1/20

[1]Oeffinger KC, Fontham ET, Etzioni R, et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society[J]. JAMA, 2015, 314(15): 1599-1614.
[2]Nelson HD, Pappas M, Cantor A, et al. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 US Preventive Services Task Force Recommendation[J]. Ann Intern Med, 2016, 164(4): 256-267.
[3]Kelly KM, Dean J, Comulada WS, et al. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts[J]. Eur Radiol, 2010, 20(3): 734-742.
[4]Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer[J]. N Engl J Med, 2007, 356(3): 227-236.
[5]Houssami N. Digital breast tomosynthesis(3D-mammography) screening: data and implications for population screening[J]. Expert Rev Med Devices, 2015, 12(4): 377-379.
[6]Friedewald SM, Rafferty EA, Rose SL, et al. Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography[J]. JAMA, 2014, 311(24): 2499-2507.
[7]Sprague BL, Stout NK, Schechter C, et al. Benefits, Harms, and Cost-Effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts[J]. Ann Intern Med, 2015, 162(3): 157-166.
[8]Saadatmand S, Rutgers ET, Tollenaar RA, et al. Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer(FaMRIsc): a multicentre randomized controlled trial[J]. BMC Cancer, 2012, 12(1): 440.
[9]Thompson DJ, Leach MO, Kwan-Lim G, et al. Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study[J]. BCR, 2009, 11(6): R80.
[10]Duygulu G, Oktay A, Bilgen IG, et al. The role of breast MRI in planning the surgical treatment of breast cancer[J]. Digan Interv Radiol, 2012, 18(5): 460-467.
[11]Sardanelli F, Podo F, Santoro F, et al. Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging(the High Breast Cancer Risk Italian 1 Study) Final Results[J]. Invest Radiol, 2011, 46(2): 94-105.
[12]Kuhl CK, Schrading S, Strobel K, et al. Abbreviated Breast Magnetic Resonance Imaging(MRI): First Postcontrast Subtracted Images and Maximum-Intensity Projection-A Novel Approach to Breast Cancer Screening With MRI[J]. J Clin Oncol, 2014, 32(22): 2304-2310.
[13]Elmore JG, Longton GM, Carney PA, et al. Diagnostic Concordance Among Pathologists interpreting Breast Biopsy Specimens[J]. JAMA, 2015, 313(11): 1122-1132.
[14]Shao H, Li B, Zhang X, et al. Comparison of the diagnostic efficiency for breast cancer in Chinese women using mammography, ultrasound, MRI, and different combinations of these imaging modalities[J]. J Xray Sci Technol, 2013, 21(21): 283-292.
[15]中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范（2015版）[J]. 中国癌症杂志，2015，25（9）：692-754.
[16]Collettini F, Martin JC, Diekmann F, et al. Diagnostic performance of a near-infrared breast imaging system as adjunct to mammography versus X-ray mammography alone[J]. Eur Radiol, 2012, 22(2): 350-357.
[17]Calderóngarciduenas AL, Sanabriamondragón M, Hernándezbeltrán L, et al. Mammographic Breast Density Patterns in Asymptomatic Mexican Women[J]. Radiol Res Pract, 2011, 2012(1): 127485.
[18]Checka CM, Chun JE, Schnabel FR, et al. The Relationship of Mammographic Density and Age: Implications for Breast Cancer Screening[J]. Am J Roentgenol, 2012, 198(3): W292-W295.
[19]Sohn YM, Kim MJ, Kwak JY, et al. Breast ultrasonography in young Asian women: analyses of BI-RADS final assessment category according to symptoms[J]. Acta Radiol, 2011, 52(1): 35-40.
[20]陈钇地，龙莉玲，彭鹏，等. ADC值和乳腺MRI征象对TICⅡ型曲线肿块样病变的诊断价值[J]. 实用放射学杂志，2018，34（3）：370-373.
[21]King V, Brooks JD, Bernstein JL, et al. Background Parenchymal Enhancement at Breast MRI Imaging and Breast Cancer Risk[J]. Radiology, 2011, 260(1): 50-60.
[22]范光荣，陈翠芬，朱志军，等. 磁共振表观扩散系数对非哺乳期乳腺炎和乳腺癌的鉴别诊断价值[J]. 临床放射学杂志，2015，34（4）：544-547.